The Translational and Innovative Nanomedicine lab was started by Dr. Isaac Adjei in 2019 and shut in 2024.
TRAIN Lab members – Fall 2021
Our lab’s mission was to employ engineering approaches to understand human diseases and develop novel therapeutic strategies.
Our lab’s focus was to understand nanoparticle-cell interactions as well as the application of nanoparticles in the treatment of various diseases such as bone metastasis and glioblastoma.
Research overview
Engineering the tumor microenvironment
Techniques for NP targeting to tissues
Modulating inflammation and hypoxia in neurological disorders
